1
Ranolazine Mediated PVC Reduction in Ischemic Heart Disease
Condition(s):Ventricular Premature Complexes; Myocardial IschemiaLast Updated:January 29, 2020Completed
Ranexa: 87 Clinical Trials, Page 1 of 9
Hide Studies Not Open or Pending
2
Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome
Condition(s):Stable Angina; Metabolic SyndromeLast Updated:April 10, 2020Completed
3
Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction
Condition(s):Pulmonary Hypertension; Diastolic Left Ventricular DysfunctionLast Updated:May 17, 2017Completed
4
Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine)
Condition(s):Chronic Stable AnginaLast Updated:April 3, 2018Unknown status
5
Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1
Condition(s):Myotonia Congenita; Paramyotonia Congenita; Myotonic Dystrophy 1Last Updated:March 5, 2019Completed
6
The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)
Condition(s):CardiomyopathyLast Updated:February 18, 2020Terminated
7
Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D
Condition(s):Diarrhea Predominant Irritable Bowel SyndromeLast Updated:March 15, 2016Terminated
8
Study to Reduce Symptoms of Premature Beats With Ranolazine
Condition(s):Premature Ventricular BeatsLast Updated:May 1, 2015Unknown status
9
Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis (MARINA)
Condition(s):Microvascular AnginaLast Updated:May 21, 2019Completed
10
Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients
Condition(s):End-stage Renal Disease; Cardiovascular DiseaseLast Updated:October 16, 2017Completed